The present invention describes storage-stable glycerol (meth)acrylate carboxylic esters and a method for preparing these esters.

Disclosed are methods for preparing cannabigerol (CBG) or a CBG analog, embodiments of the method comprising providing a compound (I); combining the compound (I) with geraniol and a solvent to form a reaction mixture; and combining the reaction mixture with an acid catalyst to form a product mixture comprising the CBG or the CBG homolog. The method may further comprise separating the CBG or the CBG analog from the product mixture and may further comprise purifying the CBG or CBG analog. Methods for preparing cannabigerolic acid (CBGA) or a cannabigerolic acid analog are also disclosed. The present disclosure also provides highly purity CBG, CBGA, and analogs thereof.

Disclosed are methods for preparing cannabigerol (CBG) or a CBG analog, embodiments of the method comprising providing a compound (I); combining the compound (I) with geraniol and a solvent to form a reaction mixture; and combining the reaction mixture with an acid catalyst to form a product mixture comprising the CBG or the CBG homolog. The method may further comprise separating the CBG or the CBG analog from the product mixture and may further comprise purifying the CBG or CBG analog. Methods for preparing cannabigerolic acid (CBGA) or a cannabigerolic acid analog are also disclosed. The present disclosure also provides highly purity CBG, CBGA, and analogs thereof.

Disclosed herein are antimicrobial compounds compositions, pharmaceutical compositions, the method of use and preparation thereof. Some embodiments relate to boronic acid derivatives and their use as therapeutic agents, for example, β-lactamase inhibitors (BLIs).

Disclosed herein are antimicrobial compounds compositions, pharmaceutical compositions, the method of use and preparation thereof. Some embodiments relate to boronic acid derivatives and their use as therapeutic agents, for example, β-lactamase inhibitors (BLIs).

The present invention relates to a method of producing a compound of formula (I) or a salt of a compound of formula (I). The invention also relates to a compound of formula (I) or a salt of a compound of formula (I) for use in a therapeutic method to achieve one or more therapeutic effects as well as for use in the treatment and/or prevention of certain diseases. Furthermore, the invention provides a pharmaceutical composition comprising one or more compound(s) of formula (I) or salt(s) of compound(s) of formula (I).

The present invention relates to a method of producing a compound of formula (I) or a salt of a compound of formula (I). The invention also relates to a compound of formula (I) or a salt of a compound of formula (I) for use in a therapeutic method to achieve one or more therapeutic effects as well as for use in the treatment and/or prevention of certain diseases. Furthermore, the invention provides a pharmaceutical composition comprising one or more compound(s) of formula (I) or salt(s) of compound(s) of formula (I).

A method for esterification of one or more carboxylic acid groups in a compound containing one or more carboxylic acid groups wherein the esterification reagent is a diazo-compound of formula: ##STR00001##
wherein the R.sub.1 and R.sub.2 groups of the diazo compound are selected such that the corresponding organic compound of formula: ##STR00002##
exhibits a —C—H pKa value between 18 and 29 as measured in DMSO. Specific reagents and methods for esterification are provided. The esterification reagents provided exhibit high selectivity for esterification of carboxylic acid groups over reaction with amine, alcohol or thiol groups in the compound containing one or more carboxylic acid groups. The method can be used to selectively esterify carboxylic acid groups in peptides or proteins.

A method for esterification of one or more carboxylic acid groups in a compound containing one or more carboxylic acid groups wherein the esterification reagent is a diazo-compound of formula: ##STR00001##
wherein the R.sub.1 and R.sub.2 groups of the diazo compound are selected such that the corresponding organic compound of formula: ##STR00002##
exhibits a —C—H pKa value between 18 and 29 as measured in DMSO. Specific reagents and methods for esterification are provided. The esterification reagents provided exhibit high selectivity for esterification of carboxylic acid groups over reaction with amine, alcohol or thiol groups in the compound containing one or more carboxylic acid groups. The method can be used to selectively esterify carboxylic acid groups in peptides or proteins.

Alkoxylates according to the following formula (I)

##STR00001##

are described, wherein X is selected from ethoxy and mixtures of ethoxy and propoxy groups, T is selected from the group consisting of H, C.sub.1-C.sub.4 alkyl, SO.sub.3.sup.−, CH.sub.2—COO.sup.−, sulfosuccinate and PO.sub.3.sup.2−, R1, R2 and R4 are H, CO—NR8R3 or COO—[X.sub.1].sub.v—R3, whereby two of the substituents R1, R2 and R4 are H and the third of these substituents is CO—NR8R3 or COO—[X.sub.1].sub.v—R3, R8 is H or a linear or branched alkyl group with 1 to 4 C-atoms, R3 is a linear or branched saturated alkyl group with 6 to 30 carbon atoms, a linear or branched mono- or polyunsaturated alkenyl group with 6 to 30 carbon atoms, an aryl group with 6 to 10 carbon atoms, a group (CH.sub.2CH.sub.2O).sub.maryl, wherein the aryl group comprises 6 to 10 carbon atoms and m, on a molar average, is a number from 1 to 100, or an aryl-substituted linear or branched C.sub.1-C.sub.3 alkyl group wherein the aryl group comprises 6 to 10 carbon atoms, but in the case, that R1 and R4 are H and R2 is COOR3, R3 can only be an alkyl group, an alkenyl group or a group (CH.sub.2CH.sub.2O).sub.maryl as defined above, X.sub.1 is selected from ethoxy and mixtures of ethoxy and propoxy groups, u on a molar average, is a number of from 3 to 100, and v on a molar average, is a number of from 0 to 20.

The compounds of formula (I) may advantageously be used as anti-redeposition agents in laundry applications.